Stay updated on Pembrolizumab vs Chemo in Advanced Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Chemo in Advanced Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Chemo in Advanced Esophageal Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in a medical study related to the treatment of advanced esophageal/​esophagogastric junction carcinoma using pembrolizumab or chemotherapy.
    Difference
    0.1%
    Check dated 2024-06-06T14:27:54.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study, specifying the required diagnosis, disease status, life expectancy, and other health conditions. Previously, this section only indicated that no information was provided.
    Difference
    30%
    Check dated 2024-05-22T21:25:16.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:25:22.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Chemo in Advanced Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Chemo in Advanced Esophageal Cancer Clinical Trial page.